Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (239)
PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION
1989 • 1,845 citations
Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable Angina
1983 • 1,740 citations
Aspirin Use and Reduced Risk of Fatal Colon Cancer
1991 • 1,695 citations
Isolated noncompaction of left ventricular myocardium. A study of eight cases.
1990 • 1,394 citations
The Existence of Publication Bias and Risk Factors for Its Occurrence
1990 • 1,335 citations
Aspirin, Heparin, or Both to Treat Acute Unstable Angina
1988 • 1,290 citations
A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk Patients
1989 • 1,209 citations
Randomised trial of prophylactic daily aspirin in British male doctors
1988 • 1,178 citations
Aspirin, Sulfinpyrazone, or Both in Unstable Angina
1985 • 1,146 citations
THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE
1989 • 912 citations
Publication bias: the case for an international registry of clinical trials.
1986 • 750 citations
Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary Angioplasty
1988 • 696 citations
Controlled trial of aspirin in cerebral ischemia.
1977 • 633 citations
"AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia.
1983 • 615 citations
A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement
1993 • 563 citations
A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass Operations
1982 • 550 citations
Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass Operations
1984 • 529 citations
A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial Infarction
1974 • 517 citations
Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris
1992 • 509 citations
Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study.
1988 • 429 citations
Endothelium-derived relaxing factor and coronary vasospasm.
1989 • 423 citations
Why do we need systematic overviews of randomized trials? (Transcript of an oral presentation, modified by the editors)
1987 • 404 citations
Aspirin use and chronic diseases: a cohort study of the elderly.
1989 • 398 citations
Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group.
1990 • 387 citations
Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study.
1984 • 363 citations
Pharmacologic Control of Thromboembolic Complications of Cardiac-Valve Replacement
1971 • 353 citations
Suppression of Thromboxane A2but Not of Systemic Prostacyclin by Controlled-Release Aspirin
1991 • 333 citations
Programmed electrical stimulation of the heart in patients with life-threatening ventricular arrhythmias: what is the significance of induced arrhythmias and what is the correct stimulation protocol?
1985 • 301 citations
The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials.
1993 • 292 citations
Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study
1990 • 278 citations
DRUG-INDUCED INHIBITION OF PLATELET FUNCTION DELAYS PROGRESSION OF PERIPHERAL OCCLUSIVE ARTERIAL DISEASE
1985 • 261 citations
Persantine-aspirin reinfarction study. Part II. Secondary coronary prevention with persantine and aspirin
1986 • 254 citations
Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
1989 • 251 citations
Prevention of Thrombosis in Patients on Hemodialysis by Low-Dose Aspirin
1979 • 248 citations
Comparison of Warfarin, Low-Molecular-Weight Dextran, Aspirin, and Subcutaneous Heparin in Prevention of Venous Thromboembolism following Total Hip Replacement
1974 • 241 citations
Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study (CARPORT).
1991 • 239 citations
Low-Dose Aspirin Therapy for Chronic Stable Angina
1991 • 227 citations
Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials.
1993 • 214 citations
PANCURONIUM PREVENTS PNEUMOTHORACES IN VENTILATED PREMATURE BABIES WHO ACTIVELY EXPIRE AGAINST POSITIVE PRESSURE INFLATION
1984 • 207 citations
Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group.
1993 • 206 citations
Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study.
1993 • 204 citations
Randomized Clinical Trial of Daily Aspirin Therapy in Multi‐Infarct Dementia
1989 • 195 citations
Reduction in Venous Thromboembolism by Agents Affecting Platelet Function
1971 • 194 citations
Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study.
1983 • 192 citations
Prevention of arterial thromboembolism with acetylsalicylic acid
1977 • 191 citations
Controlled Trial of Dipyridamole in Cerebral Vascular Disease
1969 • 183 citations
Avoidance of large biases and large random errors in the assessment of moderate treatment effects: The need for systematic overviews
1987 • 180 citations
Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves
1976 • 172 citations
Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery.
1985 • 172 citations
Controlled trial of aspirin in cerebral ischemia. Part II: surgical group.
1978 • 171 citations
Failure of Antiplatelet and Anticoagulant Therapy to Improve Patency of Grafts after Coronary-Artery Bypass
1979 • 171 citations
Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial.
1985 • 157 citations
Prevention of aorta-coronary bypass graft occlusion. Beneficial effect of ticlopidine on early and late patency rates of venous coronary bypass grafts: a double-blind study.
1987 • 149 citations
The FDA's Critique of the Anturane Reinfarction Trial
1980 • 149 citations
Arteriovenous-Shunt Thrombosis
1974 • 144 citations
Effect of pretreatment with aspirin versus aspirin plus dipyridamole on frequency and type of acute complications of percutaneous transluminal coronary angioplasty
1990 • 135 citations
Effects of aspirin and dipyridamole on expanded polytetrafluoroethylene graft patency.
1982 • 134 citations
Antiplatelet drugs in femoropopliteal vein bypasses: A multicenter trial
1991 • 129 citations
Aspirin and human platelets: from clinical trials to acetylation of cyclooxygenase and back
1989 • 127 citations
Effect of aspirin and dipyridamole on the patency of lower extremity bypass grafts.
1984 • 127 citations
Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial.
1989 • 123 citations
TRIAL OF LOW-DOSE ASPIRIN PLUS DIPYRIDAMOLE VERSUS ANTICOAGULANTS FOR PREVENTION OF AORTOCORONARY VEIN GRAFT OCCLUSION
1989 • 120 citations
Secondary Prevention of Myocardial Infarction: a Comparison of Acetylsalicylic Acid, Placebo and Phenprocoumon
1980 • 111 citations
Prevention of one-year vein-graft occlusion after aortocoronary- bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants
1993 • 111 citations
Influence of Aspirin and Dipyridamole on Patency of Coronary Artery Bypass Grafts
1981 • 109 citations
Multicenter Double-Blind Study of Ticlopidine in the Treatment of Intermittent Claudication and the Prevention of its Complications
1988 • 106 citations
Anticoagulant vs anti-platelet therapy as prophylactic against cerebral infarction in transient ischemic attacks.
1980 • 105 citations
Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Grupo Español para el Seguimiento del Injerto Coronario (GESIC)
1990 • 98 citations
A randomized trial of aspirin and sulfinpyrazone in patients with TIA.
1982 • 97 citations
Evaluation of flurbiprofen for prevention of reinfarction and reocclusion after successful thrombolysis or angioplasty in acute myocardial infarction
1993 • 96 citations
Effect of picotamide on the clinical progression of peripheral vascular disease. A double-blind placebo-controlled study. The ADEP Group.
1993 • 95 citations
The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Design, organization, and baseline results.
1988 • 94 citations
Extra-Cranial Bleeding and Other Symptoms due to Low Dose Aspirin and Low Intensity Oral Anticoagulation
1992 • 94 citations
Does 111indium-platelet deposition predict patency in prosthetic arterial grafts?
1983 • 92 citations
Studies with a new coronary vasodilator drug: Persantin
1962 • 90 citations
Dose-dependent effect of aspirin on carotid atherosclerosis.
1993 • 87 citations
Random control trial of a short course of aspirin and dipyridamole (Persantin) for femorodistal grafts
1987 • 87 citations
Deep vein thrombosis in spinal cord injury: effect of prophylaxis with calf compression, aspirin,and dipyridamole
1982 • 85 citations
Platelet function in coronary artery disease: effects of coronary surgery and sulfinpyrazone.
1982 • 84 citations
EFFECT OF DIPYRIDAMOLE ON THE INCIDENCE OF CLINICALLY DETECTABLE DEEP-VEIN THROMBOSIS
1969 • 79 citations
Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass
1988 • 77 citations
TWO IN-VIVO STUDIES COMPARING HIGH AND LOW ASPIRIN DOSAGE
1971 • 74 citations
The role of sulfinpyrazone in the prevention of arterio-venous shunt thrombosis.
1975 • 71 citations
Prevention of serious cardiac events by low-dose aspirin in patients with silent myocardial ischaemia
1992 • 70 citations
Prevention of p.o. clotting of av. cimino fistulae with Acetylsalicyl acid results of a prospective double blind study
1974 • 69 citations
Effects of sulfinpyrazone on early graft closure after myocardial revascularization
1982 • 68 citations
Acetylsalicylic acid and dipyridamole improve the early patency of aorta-coronary bypass grafts. A double-blind, placebo-controlled, randomized trial.
1985 • 68 citations
Effect of Ticlopidine on Saphenous Vein Bypass Patency Rates: A Double-blind Study
1984 • 68 citations
Effect of eicosapentaenoic acid on restenosis rate, clinical course and blood lipids in patients after percutaneous transluminal coronary angioplasty
1990 • 68 citations
Dipyridamole: a Controlled Trial of its Effect in Acute Myocardial Infarction
1968 • 65 citations
Indobufen in the prevention of thromboembolic complications in patients with heart disease. A randomized, placebo-controlled, double-blind study.
1993 • 62 citations
Equal Antiplatelet Effects of Aspirin 50 or 324 mg/Day in Patients After Acute Myocardial Infarction
1985 • 61 citations
Reocclusion Prophylaxis with Dipyridamole Combined with Acetylsalicylic Acid Following PTA
1990 • 60 citations
Treatment after transient ischemic attacks: a comparison between anticoagulant drug and inhibition of platelet aggregation.
1983 • 60 citations
Antithrombotic therapy with ticlopidine in chronic renal failure patients on maintenance hemodialysis -a multicenter collaborative double blind study-
1980 • 59 citations
[Prevention of recurrences of cerebral ischemic vascular accidents by platelet antiaggregants. Results of a 3-year controlled therapeutic trial].
1982 • 59 citations
Controlled trial of low-dose heparin and sulfinpyrazone to prevent venous thromboembolism after operation on the hip.
1978 • 58 citations
The detection and prevention of pulmonary embolism in total hip replacement. A study comparing aspirin and low-dose warfarin.
1982 • 58 citations
A secondary prevention, randomized trial of suloctidil in patients with a recent history of thromboembolic stroke.
1985 • 57 citations
Double‐Blind Randomized Trial of the Effect of Ticlopidine in Arteriovenous Fistulas for Hemodialysis
1985 • 57 citations
Failure of ticlopidine to inhibit deposition of indium-111-labeled platelets on Dacron prosthetic surfaces in humans.
1984 • 56 citations
Veterans Administration Cooperative Study on Antiplatelet Agents in Diabetic Patients After Amputation for Gangrene: II. Effects of Aspirin and Dipyridamole on Atherosclerotic Vascular Disease Rates
1986 • 55 citations
SPECIFIC THROMBOXANE SYNTHETASE INHIBITION AND ALBUMIN EXCRETION RATE IN INSULIN-DEPENDENT DIABETES
1984 • 54 citations
Persistent inhibition of platelet function during long-term treatment with 75 mg acetylsalicylic acid daily in men with unstable coronary artery disease
1991 • 54 citations
Einfluß von Acetylsalicylsäure auf das Frühergebnis nach perkutaner Rekanalisation arterieller Obliterationen nach Dotter
1973 • 53 citations
Preventive Treatment of Cerebral Transient Ischemia: Comparative Randomized Trial of Pentoxifylline versus Conventional Antiaggregants
1985 • 50 citations
A randomized controlled trial of aspirin in the prevention of early mortality in myocardial infarction.
1979 • 50 citations
Treatment program and comparison between anticoagulants and platelet aggregation inhibitors after transient ischemic attack.
1981 • 49 citations
A randomized trial of aspirin or heparin in hospitalized patients with recent transient ischemic attacks. A pilot study.
1989 • 49 citations
125I Fibrinogen and the Prevention of Venous Thrombosis
1973 • 48 citations
EFFECTS OF PLATELET INHIBITION ON MYOCARDIAL ISCHAEMIA
1982 • 47 citations
Favorable effect of sulfinpyrazone on thromboembolism in patients with rheumatic heart disease.
1980 • 47 citations
Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial
1989 • 46 citations
Prevention of early reocclusion by dipyridamole and ASA in arterial reconstructive surgery.
1981 • 45 citations
Attempts to reduce arterial thrombosis after cardiac catheterization in children: Use of percutaneous technique and aspirin
1974 • 45 citations
RANDOMISED TRIAL OF PENTOXIFYLLINE VERSUS ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE IN PREVENTING TRANSIENT ISCHAEMIC ATTACKS
1981 • 43 citations
EFFECTS OF INTERMITTENT TREATMENT WITH ASPIRIN ON THROMBOXANE AND PROSTACYCLIN FORMATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
1988 • 43 citations
Effect of drugs that suppress platelet surface interaction on incidence of amaurosis fugax and transient cerebral ishcemia.
1972 • 41 citations
ACETYLSALICYLIC ACID AND ARTERIOSCLEROTIC THROMBOEMBOLIC DISEASES IN THE AGED
1971 • 41 citations
Dipyridamole and postoperative ischemic deficits in aneurysmal subarachnoid hemorrhage
1985 • 40 citations
Therapeutic Effect of Ticlopidine, a New Inhibitor of Platelet Aggregation, on Chronic Arterial Occlusive Diseases, a Double-blind Study versus Placebo
1982 • 39 citations
The influence of ticlopidine on the natural course of retinal vein occlusion.
1984 • 39 citations
Platelet inhibition with Ticlopidine in atherosclerotic intermittent claudication.
1982 • 37 citations
Failure of Aspirin plus Dipyridamole To Prevent Restenosis after Carotid Endarterectomy
1992 • 37 citations
Verhütung von Wiederverschlüssen nach Rekanalisation obliterierter Arterien mit der Kathetermethode
1978 • 35 citations
Low-dose acetylsalicylic acid (ASA) plus dipyridamole versus dipyridamole alone in the prevention of stroke in patients with reversible ischemic attacks
1987 • 35 citations
Controlled Double-blind Trial of "Persantin" in Treatment of Angina Pectoris
1960 • 35 citations
Blood Conservation with Membrane Oxygenators and Dipyridamole
1987 • 34 citations
Effect of perioperative platelet inhibition on postcarotid endarterectomy mural thrombus formation
1985 • 33 citations
A double-blind trial of suloctidil v. Placebo in intermittent claudication
1982 • 31 citations
Effect of athrombogenic therapy, especially high dose therapy of dipyridamole, after prosthetic valve replacement.
1975 • 30 citations
[Use of acetylsalicylic acid in the prevention of re-occlusion following revascularization interventions. Results of a double-blind long term study].
1977 • 29 citations
Einfluß von Ticlopidin auf die periphere obliterierende Arteriopathie
2008 • 29 citations
Sulphinpyrazone in acute myocardial infarction: studies on cardiac rhythm and renal function.
1980 • 29 citations
Dipyridamole in the treatment of angina pectoris. A double-blind evaluation.
1967 • 28 citations
Antiplatelet drugs improve the patency rates after femoro-popliteal endarterectomy.
1985 • 27 citations
Administration of aspirin-dipyridamole reduces proteinuria in diabetic nephropathy.
1989 • 27 citations
A randomized trial of aspirin and sulfinpyrazone in patients with threatened stroke. Results and methodologic issues.
1980 • 27 citations
Two year Cottbus reinfarction study with 30 mg aspirin per day
1991 • 26 citations
Platelet adhesiveness in patients with cerebral vascular disease
1972 • 26 citations
Double-blind trial of aspirin in patients receiving tranexamic acid for subarachnoid haemorrhage
1982 • 26 citations
Effects of Ticlopidine on the Neurologic Outcome and the Hemorheologic Pattern in the Postacute Phase of Ischemic Stroke: A Pilot Study
1990 • 26 citations
Treatment of claudication with dipyridamole and aspirin.
1986 • 25 citations
Controlled Trial of Suloctidil in Intermittent Claudication
1981 • 25 citations
[Quantitative assessment of drug-induced prophylaxis of postoperative thromboembolism. Comparison of frequencies of deep vein thrombosis and pulmonary embolism using acetylsalicylic-acid, dextran, dihydroergotamine, low-dose heparin and the fixed combination of heparin and dihydroergotamine (author's transl)].
1977 • 24 citations
A Prospective Randomized Trial of Aspirin in Femoral Popiteal and Tibial Bypass Grafts
1985 • 24 citations
Low‐dose acetylsalicylic acid (100 mg/day) after aortocoronary bypass surgery: a placebo‐controlled trial.
1984 • 23 citations
Effect of Aspirin on Brachial Artery Occlusion following Brachial Arteriotomy for Coronary Arteriography
1973 • 23 citations
Controlled trial of aspirin in cerebral ischemia
1986 • 23 citations
Effects of platelet suppressant, anticoagulant and fibrinolytic therapy in patients with recurrent venous thrombosis
1978 • 23 citations
Platelet inhibitors versus anticoagulants for prevention of aorto-coronary bypass graft occlusion
1985 • 23 citations
Treatment of angina pectoris with dipyridamole: A long-term double blind study
1967 • 23 citations
Persantin—a Double Blind Study
1964 • 22 citations
The Canadian trial of aspirin and sulfinpyrazone in threatened stroke
1980 • 21 citations
Effect of ticlopidine on blood loss, platelet turnover and platelet deposition on prosthetic surfaces in patients undergoing aorto-femoral bypass grafting
1991 • 21 citations
Ticlopidine—Pentoxifylline Combination in the Treatment of Atherosclerosis and the Prevention of Cerebrovascular Accidents
1989 • 21 citations
Effects of Ticlopidine of Platelet Function in Men with Stable Angina Pectoris
1985 • 19 citations
TRIAL OF DIPYRIDAMOLE-ASPIRIN IN RECURRING VENOUS THROMBOSIS
1980 • 19 citations
Combination of suloctidil and anticoagulation in the prevention of reocclusion after femoro-popliteal PTA.
1987 • 19 citations
Prevention of thromboembolism in total hip replacement: Aspirin versus dihydroergotamine-heparin
1987 • 19 citations
Multi-Hospital Eastern Atlantic Restenosis Trial II: A placebo-controlled trial of thromboxane blockade in the prevention of restenosis following coronary angioplasty
1991 • 19 citations
Usefulness of aspirin plus dipyridamole in reducing left ventricular thrombus formation in anterior wall acute myocardial infarction
1989 • 19 citations
Enteric-coated acetylsalicylic acid plus dipyridamole compared with anticoagulants in the prevention of ischemic events in patients with transient ischemic attacks
2009 • 19 citations
Effect of aspirin on exercise‐induced angina
1978 • 18 citations
Efficacy of Indobufen in the Treatment of Intermittent Claudication
1988 • 18 citations
Improved Patency of the Aortocoronary Bypass by Antithrombotic Drugs
1986 • 18 citations
Combined Administration of Low Dose Heparin and Aspirin as Prophylaxis of Deep Vein Thrombosis after Hip Joint Surgery
1976 • 18 citations
Thrombosis prevention with ticlopidine after femoropopliteal thromboendarterectomy.
1986 • 18 citations
Modified “low-dose” heparin prophylaxis to reduce thrombosis after hip joint operations
1978 • 16 citations
Dextran/aspirin versus heparin/dihydroergotamine in preventing thrombosis after hip fractures
1985 • 16 citations
Effects of the platelet inhibitor ticlopidine on exercise tolerance in stable angina pectoris
1987 • 16 citations
The effect of acetylsalicylic acid on the outcome after lower limb arterial surgery with special reference to cigarette smoking
1991 • 15 citations
[Thromboembolic complications and their prevention in total hip replacement (author's transl)].
1978 • 15 citations
Antiplatelet therapy following carotid bifurcation endarterectomy. Evaluation of a controlled clinical trial. Prognostic significance of histologic plaque examination on behalf of survival
1990 • 15 citations
Effect of therapy on platelet activating factor-induced aggregation in acute stroke.
1989 • 15 citations
Aspirin Pretreatment Prevents Post-cannulation Radial-artery Thrombosis
1979 • 15 citations
The North American ticlopidine aspirin stroke study: structure, stratification variables, and patient characteristics.
1984 • 15 citations
The Effect of Ticlopidine upon Platelet Function, Haemorrhage and Post-Operative Thrombosis in Patients Undergoing Suprapubic Prostatectomy
1981 • 14 citations
Triflusal versus acetylsalicylic acid: a double-blind study for the prophylaxis of deep vein thrombosis after hip surgery.
1991 • 14 citations
Transient cerebral ischaemic attacks—management and prognosis
1981 • 14 citations
The Effect of Ticlopidine on Platelet Functions in Acute Myocardial Infarction
1985 • 14 citations
[Late results of conservative therapy of arterial occlusive diseases].
1984 • 13 citations
Effect of Dipyridamole (Persantin®) on Blood Flow and Patency of Aortocoronary Vein Bypass Grafts
1990 • 13 citations
Ticlopidine: quo vadis? Subarachnoid hemorrhage.
1984 • 13 citations
[The treatment of transitory ischemic attacks with acetylsalicylic acid: results of a double-blind-study (author's transl)].
1980 • 13 citations
Effects of Suloctidil on Platelet Survival Time Following Cardiac Valve Replacement
1981 • 12 citations
Thromboxane receptor blockade versus cyclooxigenase inhibition: Antiplatelet effects in patients
1986 • 12 citations
Sulfinpyrazone and Postoperative Deep Vein Thrombosis
1977 • 11 citations
Clinical and Biological Activity of the Antiplatelet Agent Suloctidil in Treatment of Idiopathic Recurrent Vein Thrombosis (I.R.V.T.)
1982 • 11 citations
Effect of treatment with an inhibitor of platelet aggregation on the evolution of background retinopathy: 2 years of follow-up
1989 • 10 citations
[Prevention of reinfarction with acetylsalicylic acid].
1979 • 10 citations
A platelet aggregation inhibitor--ticlopidine--in diabetic nephropathy: a randomized double blind study.
1984 • 10 citations
Failure of combined acetylsalicylic acid and dipyridamole to prevent occlusion of aortocoronary venous bypass graft
1987 • 10 citations
V.A. cooperative study on antiplatelet agents in diabetic patients after amputation for gangrene: I. Design, methods, and baseline characteristics
1984 • 9 citations
Prevention of Recurrent Deep Venous Thrombosis with Indobufen. A 3-Year Follow-up Study Using Color Duplex Scanning
1993 • 9 citations
Reduction of platelet activity in patients with prosthetic heart valves.
1980 • 9 citations
Niedrig dosiertes Heparin und Acetylsalicylsäure nach elektiven Operationen am Hüftgelenk
1977 • 8 citations
ASA-dipyridamole prophylaxis in elective total hip replacement.
1978 • 8 citations
[Controlled cooperative trial of secondary prevention of cerebral ischemic accidents caused by atherosclerosis, using aspirin and dipyridamole].
1983 • 7 citations
Prophylaxis of venous thromboembolism by aspirin, warfarin and heparin in patients with hip fracture. A prospective clinical study with cost-benefit analysis.
1984 • 7 citations
The Incidence of Deep Venous Thrombosis in Patients with an Acute Myocardial Infarction Treated with Acenocoumarol or Indobufen
1982 • 7 citations
Pathogenesis and prevention of aortocoronary bypass graft occlusion.
1986 • 7 citations
Medical treatment of intermittent claudication: A comparative double-blind study of suloctidil, dihydroergotoxine and placebo
1976 • 7 citations
Are anti‐platelet drugs of value in the management of patients with chronic stable angina? A study with ticlopidine
1986 • 7 citations
The Effect of a Platelet Inhibiting Drug (Sulfinpyrazone) in the Therapy of Patients with Transient Ischemic Attacks (Tia’s) and Minor Strokes
1975 • 7 citations
[Sulfinpyrazone (Anturan) versus placebo following surgical reconstruction of the femoral artery in arterial occlusive diseases].
1983 • 7 citations
Intermittent claudication: Suloctidil v.s. placebo treatment.
1984 • 7 citations
A Clinical Trial of Persantin and Crodimyl in the Treatment of Angina of Effort
1961 • 7 citations
Failure of thromboxane synthetase inhibition to improve exercise tolerance in patients with stable angina pectoris
1984 • 6 citations
[Treatment of unstable angina with dipyridamole combined with low doses of aspirin. A multicenter pilot double-blind controlled study].
1991 • 6 citations
[Double-blind study of the effect of dipyridamole in patients with intermittent claudication].
1992 • 6 citations
[Prophylaxis of thrombo-embolic complications in major surgery of the hip joint. A comparative controlled study with subcutaneous calcium heparinate and acetylsalicylic acid (author's transl)].
1973 • 6 citations
Ticlopidine in the secondary prevention of early diabetes-related microangiopathy: protocol of a multicenter therapeutic study (TIMAD study).
1984 • 5 citations
Prevention of venous thrombosis by dipyridamole-naproxen and low-dose heparin in patients undergoing hysterectomy.
1981 • 5 citations
[Planning, realization, and biometric evaluation of a long term study with acetylsalicylic acid].
1977 • 5 citations
Ticlopidine in the Treatment of Multiple Atherosclerotic Arteriopathy: a Strain Gauge Plethysmography and Döppler Spectrum Analysis Evaluation
1987 • 5 citations
[Evaluation of oral drugs for intermittent claudication of the legs in phase III clinical trials. Options selected for the ACT study].
1985 • 4 citations
Prevention of postoperative deep vein thrombosis by leg bandaging and oxyphenbutazone.
1976 • 4 citations
Effect of suloctidil on tomographically quantitated platelet accumulation in Dacron aortic grafts
1986 • 4 citations
[Permeability of aortocoronary bypass after 6 months. A multicenter French study].
1991 • 4 citations
[Naftidrofuryl in patients with prosthetic femoral-popliteal bypass].
1988 • 4 citations
[Randomized clinical study of the efficacy of buflomedil in the prevention of recurrence of cerebral ischemia in comparison with anti-platelet aggregation agents].
1986 • 4 citations
[Secondary prevention of cerebral infarction caused by atherosclerosis. 3-year comparison of flurbiprofen and an ergot derivative].
1984 • 3 citations
[Dipyridamole and warfarin in patients with artificial heart valve prosthesis: double-blind tests].
1985 • 3 citations
Clinical trials of an antiplatelet agent, ticlopidine, in diabetes mellitus
1983 • 3 citations
[Prevention of systemic thromboembolic accidents in patients with artificial valve prostheses. Prospective study of an antivitamins K-dipyridamole combination].
1982 • 3 citations
Ticlopidine and coronary surgery.
1984 • 3 citations
[Prevention of postoperative thromboembolism with micristin in general surgical patients (author's transl)].
1979 • 2 citations
[Study of the platelet aggregation inhibitor MICRISTIN as to its efficacy in the prevention of thromboembolism in the postoperative phase following surgical interventions].
1979 • 2 citations
[Effect of ticlopidine in the prevention of recurrences of cerebral ischemic accidents: comparative study with dipyridamol].
1984 • 2 citations
A double-blind, placebo-controlled multicentre trial of ticlopidine in patients with peripheral arterial disease in Argentina. Design, organization and general characteristics of patients at entry. The EMATAP Group.
1992 • 2 citations
[The role of colfarit in the prevention of pulmonary embolism the aged].
1988 • 1 citations
[Preventive treatment of unstable angina with aspirin (preliminary note)].
1986 • 1 citations
The effect of ibustrin on early aortocoronary bypass patency.
1990 • 1 citations
[Randomized comparative study of the recurrence rate following femoro-popliteal PTA: high (1.0 g/die) vs low (0.1 g/die) acetylsalicylic acid dose].
1991 • 1 citations
[Comparative study of 2 methods of prevention of thromboemboli in 108 cases of total hip prosthesis].
1977 • 1 citations
Thromboembolieprophylaxe bei hüftgelenknahen Oberschenkelfrakturen-Ergebnisse einer prospektiven randomisierten Studie zwischen Heparin-DHE und, ASS-DHE
1990 • 1 citations
[A combination of dihydroergotamine and acetylsalicylic acid--prevention of postoperative thromboembolic complications. Clinical study in orthopedics].
1987 • 1 citations
Dipyridamole as an Antithrombotic Drug
1988 • 1 citations